An Act to restore integrity in the marketing of pharmaceutical products and medical devices
Senate: Accompanied a study order, see S2931
Email me when S 1583 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 1583. By continuing you agree to the Terms and Privacy Policy.
Summary
The measure would prohibit any value‑bearing gifts from pharmaceutical or medical‑device manufacturers or their agents to doctors, their families, employees, facilities, or teaching programs. It also would force manufacturers to report yearly to the health department the amount, purpose, and recipient of any payments such as consulting fees or research support, making the data publicly available. The goal is to curb undue influence in prescribing and device selection.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 1583
3 free questions a day, no accountHearings
- Public Health hearing on legislation related to disease prevention, screening, and treatment, and pharmacies.Joint Committee on Public Health · Jun 11, 2025
History
- Accompanied a study order, see S2931
- Bill reported favorably by committee and referred to the committee on Health Care Financing
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Referred to the committee on Public Health
- House concurred
Sponsors
- Mark C. Montigny · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 1583 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 1583 freeOr ask your AI assistant about S 1583 directly:
Add to Claude, ChatGPT or Cursor